The serum level of al-acid glycoprotein (a1 -AGP) is significantly increased in various animal species by treatment with cytokines, glucocorticoids and phenobarbital. The mechanisms responsible for the cytokine-induced and glucocorticoid-induced increases are now well documented, but not so in the case of phenobarbital. The main purpose of this study was to assess whether phenobarbital acts on al-AGP synthesis in the liver at the transcriptional or translational level. Male Dark Agouti rats received 70 mg phenobarbital/kg daily for 7 days. The analysis of total hepatic RNA showed that a single injection of phenobarbital induced an 1 1 -fold increase in phenobarbital-dependent cytochrome P45011B mRNA, whereas seven injections of phenobarbital were required to induce a maximum 5.5-fold increase in al-AGP mRNA. Concurrently, the transcription rate of the a1 -AGP gene rose 3.5-fold. Hepatocytes isolated after the seventh injection ofphenobarbital showed a threefold increased capacity to secrete a1 -AGP, corresponding to a 3.2-fold increased a1-AGP mRNA content in the liver. In conditions in which its effect on the induction of al-AGP synthesis was maximum, phenobarbital caused a 30% reduction in liver albumin mRNA and in albumin secretion by isolated hepatocytes, resulting from a 60-70% reduction in the rate of transcription of the albumin gene measured in isolated nuclei. We conclude that the effect of phenobarbital on al-AGP and albumin gene expression occurs at the transcriptional rather than the translational level.Alpha1 -acid glycoprotein (a1 -AGP) or orosomucoid, is one of the major acute-phase reactants in man, mice and rats, and its serum concentration increases several-fold in response to inflammation and infection [l]. Conversely, the serum level of negative acute-phase proteins such as albumin decreases slightly. These changes in serum protein concentrations have been correlated with a sharp increase in al-AGP mRNA and a slight decrease in albumin mRNA in the liver [2, 31. Birch and Schreiber [4] have shown that the increase in al-AGP mRNA is regulated at both the transcriptional and posttranscriptional levels.The cytokines involved in the hepatic acute-phase reaction can directly stimulate the hepatic synthesis of some acutephase proteins, particularly ctl -AGP, both in viva and in vitro; however, contrary to turpentine treatment, they are not able to elicit a full-scale hepatic acute response. The addition of interleukin I (ILI) or interleukin 6 (IL6) to primary rat hcpatocyte culturcs [5, 61, IL1 to cultures of rat hepatoma cells [7, 81, IL1, IL6 or tumor necrosis factor a, to human hepatoma cells [5, 9, 101 and IL1 or IL6 to of mouse hepatocytes [ l l ] enhances both the secretion of al-AGP and the level of the corresponding cellular mRNA. A similar enhancement has been found after treatment of rats with IL6 [12], IL1 [13-161 and tumor necrosis factor CI [17]. I n vivo, IL1 appears to be a more potent inducer ofnl-AGP than IL6, in terms of the maximal effect on serum concentrations. As in inflam...